Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes

Manufacturer communications with providers and payers could include real-world evidence and pharmacoeconomic information, associations urge.

PS1607_FormularyCommitteePad_1200x675

The Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization released a set of principles on disseminating drug information to health care professionals and payers July 27 in the hopes of spurring the release of regulations from FDA that will enable the practice.

The “Principles on Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers” are “intended...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet